AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.
Overview
The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.
Source
Originally published at www.cnbc.com.
Related Articles
- The Nasdaq Recently Hit Correction Territory. Here's What History Says Comes Next.
- SpaceX Reports Its First-Ever Earnings Tuesday. Here Are the 5 Numbers That Will Define Whether the $1.4 Trillion Valuation Makes Any Sense.
- Here's 1 Big Clue About the Most Important Thing in the Next Crypto Bull Market
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.